Provider Statement

HMP Education

Provided by HMP Education, an HMP Global Company.

Intended Learners

This activity has been designed to meet the educational needs of physicians, pharmacists, advanced practice registered nurses, registered nurses, psychologists, psychiatrists, social workers, mental health practitioners, law enforcement, and addiction practitioners. 

Learning Objectives

After completing this activity, participants should be able to:

  • Discuss strategies to prevent stimulant abuse, provide access to treatment, and ensure that stimulants are part of larger societal discussions about addressing drug use.
  • Describe the prevalence, predictors, and consequences of prescription stimulant misuse.
  • Explain motivations for prescription stimulant misuse and how these medications are procured.
  • Discuss examples of interventions aimed at preventing prescription stimulant misuse and diversion.

Activity Overview

To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 1 year of the training will receive immediate documentation of credit. For questions regarding this educational activity, please email

Release Date: September 8, 2023
Expiration Date: September 8, 2024
Estimated Time to Complete: 8.25 hours. See individual courses for credit amounts.

Hardware/Software Requirements

The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.

Continuing Education 


In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.


HMP Education designates this enduring activity for 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This live, knowledge-based activity (Universal Activity Number: JA0006201-0000-23-037-H01-P) has been approved for 8.25 contact hours (0.825 CEUs).

The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity. HMP Education is not able to report your claimed credit after this 60-day period. Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended.


This continuing nursing education enduring activity awards 8.25 contact hours. Provider approved by the California Board of Registered Nursing, Provider #13255 for contact hours.

Nurse Practitioners

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Physician Assistants


HMP Education has been authorized by the American Academy of Physician Assistants (AAPA) to award  AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 8.25 AAPA Category 1 credits. PAs should only claim credit commensurate with the extent of their participation.


APA Logo Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

Social Workers

As a Jointly Accredited Provider, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. HMP Education maintains responsibility for this course. Social workers completing this internet enduring course 8.25 general continuing education credits.

NAADAC Addiction Professionals

This course has been approved by HMP Global, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #182840. HMP Global is responsible for all aspects of the programming.

Use Of Proprietary Names 

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

Unapproved And/Or Investigations Uses of Drugs and Devices

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of HMP Education.


The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.

The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Disclosure of Relevant Financial Relationships

HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.

Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:

  1. Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
  2. Any investigational, off-label, or non-FDA approved content or discussion

HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.

Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:

  1. All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
  2. All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
  3. Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.

All relevant financial relationships have been mitigated.


The faculty has reported the following:

Terry Bunn: Grant/Research Support–Health Research and Services Administration Award No. 6 UD9RH336310105

Dan Ciccarone: Scientific Advisory Board–Celero Systems, Arbor Pharmaceuticals; Grant/Research Support–National Institutes of Health - National Institute on Drug Abuse

Ernie Fletcher: Grant/Research Support–HRSA RCORP

Arwen Podesta: Advisory Board-Sage Surfer; Advisory Board-NAD+ Research; Advisory Board-JayMac; Affiliate-Collaborator—Psychiatry Redefined; Speakers Bureau—Alkermes, Indivior, and Pear Therapeutics

Jennifer Potter: Consultant–Atai Life Sciences, Biomedical Development Corporation, Elpida;Grant/Research Support–Texas HHS000843300001 Texas Emergency Response COVID-19 (MH/SUD) Texas HHS000562000001 (SOR) Texas Health and Human Services Commission Medication for Opioid Use Disorder Services Expansion Texas HHS000561800001 (SOR) Texas Health and Human Services Commission Medication for Opioid Use Disorder Training and Technical Assistance Center Texas HHS000963100001 (SAMHSA FG000626-01) Texas Disaster Response 2020: TDR20 NIH DAUO1DA020024 National Institute on Drug Abuse Clinical Trials Network: The Big South/West Node

Ty Schepis: Research is supported by a grant from the US National Institutes of Health, R01DA042146, and a research award from the US Food and Drug Administration, 75F40121C00148.

Madhukar H. Trivedi: Consultant–Acadia Pharmaceuticals, Inc., Alkermes Inc, Alto Neuroscience Inc, Axsome Therapeutics, GH Research Limited, GreenLight VitalSign6 Inc, Janssen, Merck Sharp & Dohme Corp., Neurocrine Biosciences Inc, Orexo US Inc, Otsuka, SAGE Therapeutics, Signant Health, Titan Pharmaceuticals, Inc.; Grant/Research Support–NIMH, NIDA, Patient-Centered Outcomes Research Institute (PCORI), Cancer Prevention Research Institute of Texas (CPRIT)

Timothy E. Wilens: Consultant – Arbor Pharmaceuticals, Remuneration to MGH, Bay Cove Human Services, Gavin Foundation, Ironshore, KemPharm, US Minor/Major League Baseball, US National Football League (ERM Associates); Other Financial or Material Support, Royalties, Intellectual Property (Co/edited textbook: ADHD in Adults and Children– Cambridge University Press; Other Financial or Material Support, Royalties, Intellectual Property (Published book: Straight Talk About Psychiatric Medications for Kids)–Guilford Press; Other Financial or Material Support, Intellectual Property (Licensing agreement: Co-owner of copyrighted Diagnostic questionnaire, the Before School Functioning Questionnaire)–Ironshore; Other Financial or Material Support, Remuneration to MGH – KemPharm; Other Financial or Material Support, Employee–Massachusetts General Hospital; Grant/Research Support–NIH (NIDA); Consultant, Other Financial or Material Support, Remuneration to MGH–Otsuka Pharmaceuticals, Vallon, White Rhino/3D

Planning Committee

Terry Bunn, PhD
Director and Research Professor
University of Kentucky

Julie Carbray, PhD, APRN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dan Ciccarone, MD, MPH
Family and Community Medicine

Ernie Fletcher, MD
Chief Medical Officer
Fletcher Group, Inc.

Rebecca Haffajee, JD, PhD, MPH
Acting Assistant Secretary for Planning and Evaluation (ASPE), Principal Deputy ASPE
U.S. Department of Health and Human Services

Laura Holt, PhD
Charles A. Dana Research Associate Professor
Trinity College

Rakesh Jain, MD
Clinical Professor
Texas Tech - Permian Basin

Lantie Jorandby, MD DFAPA
Chief Medical Officer
Lakeview Health

Gregory Mattingly, MD
Associate Clinical Professor
Washington University

Siobhan Morse, MHA
Divisional Director of Clinical Services and Product Manager SUD
Universal Health Services

Jeff Ondocsin, MAEC, MALA
University of California, San Francisco

Arwen Podesta, MD
Podesta Wellness

Jennifer Potter, PhD, MPH
Professor with Tenure
UT Health San Antonio

Daniel Rosenblum, PhD
Associate Professor
Department of Economics, Dalhousie University

Ty Schepis, PhD
Texas State University

Daniel Schwartz, BS
Health Policy Analyst
Office of the Assistant Secretary for Planning and Evaluation, U.S. Department of Health and Human Services

Steven Shoptaw, PhD
Professor and Vice Chair for Research
Department of Family Medicine Center for Behavioral and Addiction Medicine

Sally Thoren, BA, CADC
Executive Director
Gateway Foundation

Madhukar Trivedi, MD
Professor of Psychiatry; PI, Big South/West Node of the NIDA Funded Clinical Trails Network
UT Southwestern Medical Center

Hoa Vo, PhD
Assistant Research Professor
UT Southwestern Medical Center

Timothy Wilens, MD
Chief, Division of Child and Adolescent Psychiatry
Massachusetts General Hospital/Harvard Medical School

Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California

Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).

HMP Education planners and staff include Kristin Ciszeski; Krystal Scharon; Samantha Joy; Randy Robbin; and Andrea Zimmerman, EdD.

No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).

ADA Statement

HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 609.371.1137.

Privacy Policy

HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information. Copyright © 2023 by HMP Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.

Grievance Policy

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education, may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609-371-1137, by email at or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Mrs. Joy will review the grievance and respond within 30 days of receiving the complaint. 

Commercial Support

No commercial interest provided financial support for this continuing education activity. 

Contact Information

For questions regarding this educational activity, please call 609.371.1137 or email

Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.